Skip to content
News

NAFDAC destroys ₦22.7bn unsafe products, arrests 52 in eight months

The National Agency for Food and Drug Administration and Control has destroyed unwholesome products valued at about ₦22.73 billion in eight months.

It also seized 821 products and secured 52 arrests, as it intensified enforcement against unsafe and substandard regulated products.

The agency disclosed that it carried out 5,542 enforcement activities, including 213 raids, between January and August 2026.

During the period, 179 premises were shut and 221 sanctions were imposed.

The figures formed part of major regulatory milestones NAFDAC presented at the International Pharmaceutical Regulators Programme (IPRP) Management Committee Meeting in Prague, Czech Republic. The meeting was held from November 18 to 19, 2026.

The agency also reported progress in local pharmaceutical manufacturing. It disclosed that more than 70 per cent of finished pharmaceutical products covered by its 5+5 policy and Ceiling 36 are now being manufactured in Nigeria.

The development is expected to reduce dependence on imported medicines and strengthen the country’s medicine security.

In its regulatory update, NAFDAC said it had sustained its World Health Organisation (WHO) Maturity Level 3 status. It said it was working towards Maturity Level 4, the highest level of the WHO Global Benchmarking Tool.

It identified digital innovation as a critical part of the transition. It cited the Integrated Regulatory Information Management System (IRIMS), Performance Management System (i-PMS), GMP Inspection (GMPi), Application and AI-assisted Technical Screening Tools (TST), and the revised Med Safety App.

The revised application is designed to strengthen the reporting of adverse drug reactions and of substandard and falsified medical products.

NAFDAC also highlighted Nigeria’s growing influence in African pharmaceutical regulation. It noted that it had emerged as a reference National Regulatory Authority, hosting regulatory authorities from Uganda, The Gambia, Mozambique and Côte d’Ivoire for technical capacity building and institutional benchmarking.

Another milestone was Nigeria’s ratification of the African Medicines Agency (AMA) Treaty. The instruments of ratification were deposited on October 25, 2026.

The agency said the achievements reflected the strategic leadership of its Director-General, Prof. Mojisola Christianah Adeyeye. It also pointed to ongoing efforts to strengthen institutional capacity, promote science-based regulation and deepen international regulatory cooperation.

NAFDAC reaffirmed its commitment to protecting public health, strengthening Nigeria’s pharmaceutical industry and positioning the country as a leading regulatory authority in Africa.

Share

Top News